CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 63 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $171,719 | +145.3% | 29,404 | +182.4% | 0.00% | – |
| Q3 2022 | $70,000 | +25.0% | 10,412 | -37.4% | 0.00% | – |
| Q1 2022 | $56,000 | -49.5% | 16,627 | -37.0% | 0.00% | – |
| Q2 2021 | $111,000 | -31.9% | 26,404 | +58.6% | 0.00% | – |
| Q3 2020 | $163,000 | -63.9% | 16,647 | -4.4% | 0.00% | -100.0% |
| Q4 2017 | $451,000 | +46.4% | 17,421 | -14.3% | 0.00% | -50.0% |
| Q1 2015 | $308,000 | – | 20,330 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 2,610 | $620,000,000 | 6.47% |
| Parkman Healthcare Partners LLC | 1,124,072 | $4,732,000 | 1.74% |
| Kynam Capital Management, LP | 1,000,000 | $4,210,000 | 1.08% |
| EAM Investors, LLC | 850,647 | $3,581,000 | 0.87% |
| BVF INC/IL | 3,629,000 | $15,278,000 | 0.74% |
| EAM Global Investors LLC | 388,730 | $1,637,000 | 0.40% |
| RA Capital Management | 3,307,203 | $13,923,000 | 0.37% |
| Nantahala Capital Management | 1,659,840 | $6,988,000 | 0.35% |
| AWM Investment Company, Inc. | 504,661 | $2,125,000 | 0.34% |
| INGALLS & SNYDER LLC | 1,411,153 | $5,941,000 | 0.31% |